Company / R&D Expense
VIEMED HEALTHCARE, INC. R&D Expense History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$2.8M
FY2025
5-year range
$1.1M / $2.8M
FY2021-FY2025
Trend
+3.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $3M to $3M over the past 2 years.
Based on SEC 10-K filings.
$3M in FY2025 with a 5-year CAGR of +26.8%.
Improved from $3M to $3M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +9.7%
- 5-Year CAGR
- +26.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +26.8%, indicating consistent growth.
- In FY2025, r&d expense increased 3.2% year-over-year.
- Lowest r&d expense in the period was in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.8M | +3.2% |
| FY2024 | $2.7M | +0.0% |
| FY2023 | $2.7M | +27.8% |
| FY2022 | $2.1M | +94.8% |
| FY2021 | $1.1M | +27.7% |
| FY2020 | $848.0K | - |
| FY2019 | $0 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026